Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma

Overview of attention for article published in OncoTargets and therapy, May 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 85 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 34 publications that cite this research output.

34

The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.

Identification of CYFIP2 Arg87Cys Ligands via In Silico and In Vitro Approaches

Article in Biomedicines (February 2024)

Pomalidomide Improves Motor Behavioral Deficits and Protects Cerebral Cortex and Striatum Against Neurodegeneration Through a Reduction of Oxidative/Nitrosative Damages and Neuroinflammation After Traumatic Brain Injury

Article in Cell Transplantation (January 2024)

Immunomodulatory quinazoline-based thalidomide analogs: Design, synthesis, apoptosis and anticancer evaluations

Article in Journal of Molecular Structure (June 2023)